SR-58878

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSR-58878
Drug Alias NameSR-58878
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-3 adrenergic receptor agonists
TargetsBeta-3 adrenergic receptor
Therapy Area/IndicationsObesityIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi-Synthelabo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiSanofi-Synthelabo
Active IndicationsN/A
Inactive IndicationsObesityIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A